{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:48:41Z","timestamp":1787237321684,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD060860"],"award-info":[{"award-number":["R01 HD060860"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL129086"],"award-info":[{"award-number":["HL129086"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30 HD085652"],"award-info":[{"award-number":["F30 HD085652"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.peptides.2018.11.005","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T10:38:27Z","timestamp":1544265507000},"page":"96-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Genetic loss of proadrenomedullin N-terminal 20 peptide (PAMP) in mice is compatible with survival"],"prefix":"10.1016","volume":"112","author":[{"given":"Brooke C.","family":"Matson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5125-2297","authenticated-orcid":false,"given":"Claire E.","family":"Trincot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Blakeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7033-9232","authenticated-orcid":false,"given":"Kathleen M.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.peptides.2018.11.005_bib0005","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/bbrc.1993.1881","article-title":"Cloning and characterization of cDNA encoding a precursor for human adrenomedullin","volume":"194","author":"Kitamura","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2018.11.005_bib0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12879-016-1566-3","article-title":"Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.peptides.2018.11.005_bib0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11897-012-0096-6","article-title":"Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?","volume":"9","author":"Potocki","year":"2012","journal-title":"Curr. Heart Fail. Rep."},{"issue":"2","key":"10.1016\/j.peptides.2018.11.005_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ehf2.12129","article-title":"Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis","volume":"4","author":"Alma","year":"2017","journal-title":"ESC Heart Fail."},{"issue":"2","key":"10.1016\/j.peptides.2018.11.005_bib0025","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1006\/bbrc.1994.2039","article-title":"Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine","volume":"202","author":"Washimine","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.peptides.2018.11.005_bib0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/bbrc.1996.0930","article-title":"Proadrenomedullin N-terminal 20 peptide is rapidly cleaved by neutral endopeptidase","volume":"223","author":"Nagatomo","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.peptides.2018.11.005_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0014-5793(94)00810-8","article-title":"Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP)","volume":"351","author":"Kitamura","year":"1994","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.peptides.2018.11.005_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(97)00971-X","article-title":"Purification and characterization of PAMP-12 (PAMP[9\u201320]) in porcine adrenal medulla as a major endogenous biologically active peptide","volume":"414","author":"Kuwasako","year":"1997","journal-title":"FEBS Lett."},{"issue":"22","key":"10.1016\/j.peptides.2018.11.005_bib0045","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1016\/j.febslet.2005.08.007","article-title":"Overexpression of proadrenomedullin N-terminal 20 peptide blunts blood pressure rise and attenuates myocardial hypertrophy and fibrosis in hypertensive rats","volume":"579","author":"Cao","year":"2005","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.peptides.2018.11.005_bib0050","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0024-3205(99)00304-5","article-title":"Effects of PAMP on mRNAs coding for catecholamine-synthesizing enzymes in PC12 cells","volume":"65","author":"Takekoshi","year":"1999","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.peptides.2018.11.005_bib0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.HYP.28.3.325","article-title":"Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide","volume":"28","author":"Shimosawa","year":"1996","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.peptides.2018.11.005_bib0060","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1172\/JCI118208","article-title":"Proadrenomedullin NH(2)-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings","volume":"96","author":"Shimosawa","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.peptides.2018.11.005_bib0065","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbrc.2005.03.088","article-title":"Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides","volume":"330","author":"Kamohara","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.peptides.2018.11.005_bib0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.RES.84.4.445","article-title":"Proadrenomedullin N-terminal 20 peptide hyperpolarizes the membrane by activating an inwardly rectifying K+ current in differentiated PC12 cells","volume":"84","author":"Takano","year":"1999","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.peptides.2018.11.005_bib0075","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/en.2006-0105","article-title":"Molecular evolution of proadrenomedullin N-terminal 20 peptide (PAMP): evidence for gene co-option","volume":"147","author":"Martinez","year":"2006","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.peptides.2018.11.005_bib0080","first-page":"253","article-title":"Proadrenomedullin N-terminal 20 peptide inhibits aldosterone secretion of human adrenocortical and Conn\u2019s adenoma cells: comparison with adrenomedullin effect","volume":"83","author":"Andreis","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.peptides.2018.11.005_bib0085","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1471-4159.1995.64010459.x","article-title":"Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla","volume":"64","author":"Katoh","year":"1995","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.peptides.2018.11.005_bib0090","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1210\/en.2011-1685","article-title":"Proadrenomedullin N-terminal 20 peptide increases kinesin\u2019s velocity both in vitro and in vivo","volume":"153","author":"Larrayoz","year":"2012","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.peptides.2018.11.005_bib0095","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1210\/en.2007-1763","article-title":"Intracellular proadrenomedullin-derived peptides decorate the microtubules and contribute to cytoskeleton function","volume":"149","author":"Sackett","year":"2008","journal-title":"Endocrinology"},{"issue":"Pt. 5","key":"10.1016\/j.peptides.2018.11.005_bib0100","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/000456329903600510","article-title":"Increased plasma proadrenomedullin N-terminal 20 peptide in patients with essential hypertension","volume":"36","author":"Kuwasako","year":"1999","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.peptides.2018.11.005_bib0105","first-page":"S148","article-title":"Adrenomedullin and proadrenomedullin N-terminal 20 peptide in impaired renal function","volume":"55","author":"Eto","year":"1996","journal-title":"Kidney Int. Suppl."},{"issue":"4","key":"10.1016\/j.peptides.2018.11.005_bib0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/s10165-010-0295-5","article-title":"Plasma adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients diagnosed as having early rheumatoid arthritis","volume":"20","author":"Hamada","year":"2010","journal-title":"Mod. Rheumatol."},{"issue":"1","key":"10.1016\/j.peptides.2018.11.005_bib0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-2007-978980","article-title":"Plasma proadrenomedullin N-terminal 20 peptide (PAMP) in patients with congestive heart failure","volume":"29","author":"Etoh","year":"1997","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.peptides.2018.11.005_bib0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/clc.4960220211","article-title":"Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels","volume":"22","author":"Etoh","year":"1999","journal-title":"Clin. Cardiol."},{"issue":"1","key":"10.1016\/j.peptides.2018.11.005_bib0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0272-6386(99)70116-2","article-title":"Plasma and urine levels of adrenomedullin and proadrenomedullin N-terminal 20 peptide in chronic glomerulonephritis","volume":"34","author":"Kinoshita","year":"1999","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.peptides.2018.11.005_bib0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/hc0102.101399","article-title":"Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage","volume":"105","author":"Shimosawa","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.peptides.2018.11.005_bib0135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1073\/pnas.98.2.615","article-title":"Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene","volume":"98","author":"Caron","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.peptides.2018.11.005_bib0140","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/hc4101.097111","article-title":"Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene","volume":"104","author":"Shindo","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.peptides.2018.11.005_bib0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/dvdy.24065","article-title":"Epicardial-derived adrenomedullin drives cardiac hyperplasia during embryogenesis","volume":"243","author":"Wetzel-Strong","year":"2014","journal-title":"Dev. Dyn."},{"issue":"9","key":"10.1016\/j.peptides.2018.11.005_bib0150","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1073\/pnas.0611365104","article-title":"Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males","volume":"104","author":"Caron","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978118302377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978118302377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T05:42:41Z","timestamp":1565242961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978118302377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":30,"alternative-id":["S0196978118302377"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2018.11.005","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic loss of proadrenomedullin N-terminal 20 peptide (PAMP) in mice is compatible with survival","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2018.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}